ARTICLES

The game-changer for sustained growth

Enters S&P yearbook in 1st year of participation

The pharmaceutical industry is evolving rapidly, with increasing regulatory demands, complex drug formulations, and the rise of biologics challenging traditional manufacturing methods. <br> How can companies stay ahead while ensuring efficiency, quality, and compliance? <br><br> This white paper delves into Quality by Design (QbD) and Design of Experiments (DoE)—two transformative methodologies that are revolutionising drug development. <br><br> Learn how top pharmaceutical companies like Strides Pharma leverage these approaches to enhance product quality, reduce risks, optimise processes, and streamline regulatory compliance. <br><br> Get insights on: <br> ✔️ QbD’s shift from reactive testing to built-in quality <br> ✔️ DoE’s role in faster, smarter drug formulation <br> ✔️ A real-world case study on arthritis medication development <br>